Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Nov 21, 2025 · Filed Nov 24, 2025
CONMED's Chief Information Officer sold $11K of CONMED shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$10,591
Shares × reported transaction price
16 days after results of Nov 5, 2025, 68 days before results of Jan 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Filing box checked: sold under a Rule 10b5-1 plan
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.8% | +1.0% | +0.8% |
| 30 days | −5.7% | +2.3% | −8.0% |
| 90 days | +4.9% | +1.1% | +3.8% |
| 180 days | −16.6% | +11.2% | −27.8% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Derivative exercise or conversion — not an open-market buy.